World

Netanyahu approved pager attacks against Hezbollah

Nov 13, 2024

Jerusalem [Israel], November 13: Israeli Prime Minister Benjamin Netanyahu approved pager attacks that dealt a deadly blow to the Iran-backed Lebanese armed group Hezbollah in September, Omer Dostri, spokesperson for his office, said.
The Israeli military, which has been engaged in cross-border fighting with Hezbollah since the start of the Gaza war in October 2023, at first declined to respond to questions about the detonations.
On Sept. 17, thousands of pagers simultaneously exploded in the southern suburbs of Beirut and other Hezbollah strongholds, in most cases after the devices beeped, indicating an incoming message.
A Hezbollah official, speaking on condition of anonymity, said the incident was the "biggest security breach" for the group in nearly a year of conflict with Israel.
Among the victims rushed to hospital, many had eye injuries, missing fingers or gaping holes in their abdomens, Reuters witnesses saw, indicating their proximity to the devices at the time of detonation.
In total, the pager attack, and a second on the following day that activated weaponised walkie-talkies, killed 39 people and wounded more than 3,400.
Israeli media reported that Netanyahu claimed responsibility for the attack during a cabinet meeting, telling ministers that senior defence officials and political figures were opposed to the detonation of the pagers but that he went ahead with the operation.
Hezbollah fighters have been using pagers as a low-tech means of communication in an attempt to evade Israeli location-tracking, two sources familiar with the group's operations told Reuters this year.
A pager is a wireless telecommunications device that receives and displays messages.
Israel followed up the pager detonations with the killing of Hezbollah leader Hassan Nasrallah in an air strike and launching incursions in south Lebanon.
Source: Fijian Broadcasting Corporation

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025